0.1%他克莫司软膏治疗阴囊慢性湿疹效果观察

2018-09-26 03:24:34张翠松
中外医学研究 2018年14期

张翠松

【摘要】 目的:评价0.1%他克莫司软膏治疗阴囊慢性湿疹的临床效果和安全性。方法:采用随机对照法将57例患者分为两组,治疗组29例,给予0.1%他克莫司软膏外涂,每日早晚各一次;对照组28例,给予青鹏软膏外涂,用法同治疗组,疗程均为4周,于治疗第2周和第4周比较两组治疗效果,并记录不良反应。结果:治疗组治疗第2周和第4周的有效率优于对照组,差异有统计学意义(P<0.05)。治疗组药物不良反应主要表现为用药部位烧灼感和瘙痒,均可耐受,且为一过性。结论:0.1%他克莫司軟膏治疗阴囊慢性湿疹具有良好的效果,安全性高。

【关键词】 慢性湿疹; 阴囊; 他克莫司软膏

doi:10.14033/j.cnki.cfmr.2018.14.055 文献标识码 B 文章编号 1674-6805(2018)14-0-03

The Observation of the Curative Effect of 0.1% Tacrolimus Ointment in Chronic Eczema of Scrotum/ZHANG Cuisong.//Chinese and Foreign Medical Research,2018,16(14):130-132

【Abstract】 Objective:To evaluate the clinical effect and safety of 0.1% Tacrolimus Ointment for chronic eczema of scrotum.Method:Total of 57 patients with chronic eczema of scrotum were divided into the treatment group and the control group according to random control method.29 cases in the treatment group received external application of 0.1% Tacrolimus Ointment,twice a day.28 cases in the control group received external application of Qingpeng Ointment and the usage was the same as the treatment group.The course of treatment was four weeks for both groups.The efficacy of two groups after treatment was compared and the adverse reactions were recorded.Result:The effective rate in the treatment group were higher than those in the control group,after treatment of 2 weeks and 4 weeks,there were statistical differences between the groups(P>0.05).Drug related adverse reactions of the treatment group were mainly manifested as burning sensation and pruritus,which were both tolerable and transient.Conclusion:0.1% Tacrolimus Ointment is effective and safe for the treatment of chronic eczema of scrotum.

【Key words】 Chronic eczema; Scrotum; Tacrolimus ointment

First-authors address:Mentougou District Hospital of Beijing City,Beijing 102300,China

阴囊慢性湿疹是一种常见的皮肤疾病,易反复发作,常伴剧烈瘙痒,给患者带来一定困扰。笔者于2015年6月-2016年7月采用0.1%他克莫司软膏治疗反复发作的阴囊慢性湿疹,并与外用青鹏软膏相比较,取得了满意的疗效,现报告如下。

1 资料与方法

1.1 一般资料

57例男性患者均为笔者所在医院皮肤性病科门诊的患者,病例入选标准符合阴囊慢性湿疹诊断依据[1],临床表现为红斑、肥厚、脱屑、瘙痒等,所有患者对本次研究知情同意且自愿参与。排除标准:有严重心肝肾疾病及恶性肿瘤患者、近4周使用过免疫抑制剂药及系统使用糖皮质激素、对大环内酯类药物过敏者、近2周内局部使用激素药物或给予长波紫外线照射、患有脂溢性皮炎及痤疮影响观察的效果者,局部严重渗出,糜烂者均不在入选之列。随机将其分为两组,治疗组29例,年龄20~68岁,平均(29.38±5.66)岁,病程6~24个月,平均(12.14±4.84)个月。对照组28例,平均年龄(29.5±5.79)岁,病程7~25个月,平均(12.11±4.60)个月。两组患者年龄、病程比较,差异无统计学意义(P>0.05)。……

登录APP查看全文